Citius Oncology Inc Share Price

NASDAQ: CTOR

Small Cap

$1.86

+0.02

(+1.36%)

as on September 17, 2025 at 1:29 am IST

$₹

Citius Oncology Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$1.8
Day's Price Range
$1.95
$1.86
3.23%
Downside
4.84%
Upside
52 Week's Low
52 Week's High
$0.55
52-Week Price Range
$6.19
$1.86
70.40%
Downside
232.80%
Upside

Citius Oncology Inc share price movements today

Previous Close: $1.84
Open: $1.95
Volume: 394.7K
Day's Low - High: $1.8 - $1.95
52 Week Low - High: $0.55 - $6.19

Citius Oncology Inc Historical Returns

1 Month Return: + 8.88 %
3 Month Return: + 32.37 %
1 Year Return: + 12.88 %
3 Year Return: 0 %
5 Year Return: 0 %

Citius Oncology Inc Stock Fundamentals & Key Indicators

Check Citius Oncology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$149.7M

EPS (TTM)

-0.48

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

0.00%

Citius Oncology Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Citius Oncology Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Citius Oncology Inc	NA	$149.7M	NA	NA	0.00%
United Therapeutics Corporation	BUY	$18.3B	NA	15.8	40.36%
Haleon Plc Spon Ads	BUY	$44.1B	NA	21.8	13.81%
Neurocrine Biosciences Inc.	BUY	$14.1B	38.75%	42.05	13.88%
Zoetis Inc.	BUY	$65.7B	-9.3%	25.52	27.83%

Stock Returns calculator for Citius Oncology Inc Stock including INR - Dollar returns

The Citius Oncology Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Citius Oncology Inc investment value today

Current value as on today

₹1,18,978

Returns

₹18,978

(+18.98%)

Returns from Citius Oncology Inc Stock

₹14,110 (+14.11%)

Dollar Returns*

₹4,867 (+4.87%)

Citius Oncology Inc Stock's Interest Amongst Investors

Search interest for Citius Oncology Inc Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-21% versus previous 30 day period

Citius Oncology Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-
Operating Income	-4	0	0	-6	-6	-7	-4
EBITDA	1	0	0	-6	-6	-7	-4
Interest Expense	-	-	-	-	-	-	0
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-4	0	0	-6	-6	-7	-5
Income Tax Expense	0	0	0	0	0	0	0
Net Income	-4	-4	-4	-6	-6	-7	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Citius Oncology Inc Annual Profit & Loss

All numbers in Millions USD

	Sep 2022	Sep 2023	Sep 2024
Total Revenue	-	-	-
Gross Profit	-	-	-
Operating Income	-4	-12	-20
EBITDA	-4	-12	-20
Interest Expense	-	-	-
Depreciation	-	-	-
Income Before Tax	-4	-12	-20
Income Tax Expense	0	0	0
Net Income	-5	-12	-21
Net Profit Margin	0.00%	0.00%	0.00%

Citius Oncology Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-4	0	0	-6	-6	0	-5
Operating Cash Flow	0	-	0	0	-	-	-
Investing Cash Flow	0	-	0	0	-	-	-
Financing Cash Flow	0	-	0	0	-	-	-
Change in Cash	0	-	-	0	-	-	-

Citius Oncology Inc Annual Cash Flow

All numbers in Millions USD

	Sep 2023	Sep 2024
Net Income	-12	-21
Operating Cash Flow	0	0
Investing Cash Flow	-1	-5
Financing Cash Flow	1	4
Change in Cash	0	0

Insights on Citius Oncology Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, CTOR stock has moved up by 150.7%
NO EFFECT
Against Peers
In the last 1 year, United Therapeutics Corporation has given 16.9% return, outperforming this stock by 4.0%

About Citius Oncology Inc

Citius Oncology, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing targeted oncology therapies. The Company’s lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. LYMPHIR is a targeted immune therapy for relapsed or refractory cutaneous T-cell lymphoma (CTCL) indicated for use in Stage I-III disease after at least one prior systemic therapy. It is a recombinant fusion protein that combines the IL-2 receptor binding domain with diphtheria toxin fragments. The agent specifically binds to IL-2 receptors on the cell surface, causing diphtheria toxin fragments that have entered cells to inhibit protein synthesis. After uptake into the cell, the diphtheria toxin (DT) fragment is cleaved and the free DT fragments inhibit protein synthesis, resulting in cell death.

Organisation	Citius Oncology Inc
Headquarters	11 Commerce Drive, Cranford, NJ, United States, 07016
CEO	Mr. Leonard L. Mazur
E-voting on shares	Click here to vote

Key Management of Citius Oncology Inc

Name	Title
Mr. Leonard L. Mazur	CEO, President & Executive Chairman
Mr. Myron Z. Holubiak	Secretary & Executive Vice Chairman
Dr. Myron S. Czuczman M.D.	Chief Medical Officer
Mr. Jaime Bartushak	CFO & Treasurer

FAQs

What is Citius Oncology Inc share price today?

Citius Oncology Inc share price today is $1.86 as on September 17, 2025 at 1:29 am IST at the close of the market. Citius Oncology Inc share today touched a day high of $1.95 and a low of $1.8.

What is the 52 week high and 52 week low for Citius Oncology Inc share?

Citius Oncology Inc share touched a 52 week high of $6.19 on June 27, 2025 and a 52 week low of $0.55 on March 17, 2025. Citius Oncology Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $1.86,which is 69.95% down from its 52 week high and 237.81% up from its 52 week low.

What is Citius Oncology Inc's market capitalisation today?

Citius Oncology Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Citius Oncology Inc Stock (CTOR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Citius Oncology Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Citius Oncology Inc Shares that will get you 0.8065 shares as per Citius Oncology Inc share price of $1.86 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Citius Oncology Inc Stock (CTOR) from India?

Indian investors can start investing in Citius Oncology Inc (CTOR) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 3:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Citius Oncology Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 3:38 am IST). Based on Citius Oncology Inc share’s latest price of $1.86 as on September 17, 2025 at 1:29 am IST, you will get 5.3763 shares of Citius Oncology Inc. Learn more about fractional shares .